{"id":"https://openalex.org/W4320032575","doi":"https://doi.org/10.1080/23744235.2023.2177337","title":"In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre","display_name":"In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre","publication_year":2023,"publication_date":"2023-02-10","ids":{"openalex":"https://openalex.org/W4320032575","doi":"https://doi.org/10.1080/23744235.2023.2177337","pmid":"https://pubmed.ncbi.nlm.nih.gov/36772806"},"language":"en","primary_location":{"id":"doi:10.1080/23744235.2023.2177337","doi":"https://doi.org/10.1080/23744235.2023.2177337","is_oa":false,"landing_page_url":"https://doi.org/10.1080/23744235.2023.2177337","pdf_url":null,"source":{"id":"https://openalex.org/S200495913","display_name":"Scandinavian Journal of Infectious Diseases","issn_l":"0036-5548","issn":["0036-5548","1651-1980","2374-4235","2374-4243"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066544234","display_name":"Jenna Adams","orcid":"https://orcid.org/0009-0002-1589-6877","observed_orcids":["https://orcid.org/0009-0002-1589-6877","https://orcid.org/0000-0002-7137-6529"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jenna Adams","raw_affiliation_strings":["Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082012588","display_name":"Maressa Santarossa","orcid":"https://orcid.org/0000-0002-2128-5813","observed_orcids":["https://orcid.org/0000-0002-2128-5813"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maressa Santarossa","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, USA","Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, USA","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]},{"raw_affiliation_string":"Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113861172","display_name":"Amanda Harrington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Harrington","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Loyola University Chicago, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Loyola University Chicago, Maywood, IL, USA","institution_ids":["https://openalex.org/I1925986","https://openalex.org/I4210159390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041397944","display_name":"Michael Bauer","orcid":"https://orcid.org/0000-0002-2666-859X","observed_orcids":["https://orcid.org/0000-0002-2666-859X"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Bauer","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Loyola University Chicago, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Loyola University Chicago, Maywood, IL, USA","institution_ids":["https://openalex.org/I1925986","https://openalex.org/I4210159390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070962895","display_name":"Amy W. Wozniak","orcid":"https://orcid.org/0000-0002-0670-3677","observed_orcids":["https://orcid.org/0000-0002-0670-3677"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Wozniak","raw_affiliation_strings":["Clinical Research Office, Loyola University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Office, Loyola University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080500849","display_name":"Laurie Labuszewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurie Labuszewski","raw_affiliation_strings":["Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Loyola University Medical Center, Maywood, IL, USA","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089306674","display_name":"Fritzie S Albarillo","orcid":"https://orcid.org/0000-0002-3441-301X","observed_orcids":["https://orcid.org/0000-0002-3441-301X"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fritzie S. Albarillo","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, USA"],"raw_orcid":"https://orcid.org/0000-0002-3441-301X","affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Loyola University Medical Center, Maywood, IL, USA","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066544234"],"corresponding_institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"],"apc_list":null,"apc_paid":null,"fwci":0.1235,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.30492167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"55","issue":"4","first_page":"282","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbapenem-resistant-enterobacteriaceae","display_name":"carbapenem-resistant Enterobacteriaceae","score":0.9950000047683716},{"id":"https://openalex.org/keywords/meropenem-vaborbactam","display_name":"meropenem-vaborbactam","score":0.972000002861023},{"id":"https://openalex.org/keywords/ceftazidime-avibactam","display_name":"ceftazidime-avibactam","score":1.0},{"id":"https://openalex.org/keywords/klebsiella-pneumoniae-carbapenemase","display_name":"KPC","score":0.9610000252723694},{"id":"https://openalex.org/keywords/carbapenemase-gene-detection","display_name":"carbapenemase gene detection","score":0.6150000095367432},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.7289999723434448},{"id":"https://openalex.org/keywords/microbiologic-cure","display_name":"microbiologic cure","score":0.7210000157356262},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7599999904632568},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.7289999723434448},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.39800000190734863},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C2775933652","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Ceftazidime/avibactam","level":5,"score":0.9786503911018372},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7480103373527527},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.702121913433075},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.6671552658081055},{"id":"https://openalex.org/C2777406300","wikidata":"https://www.wikidata.org/wiki/Q15410251","display_name":"Avibactam","level":5,"score":0.6135420799255371},{"id":"https://openalex.org/C2775992322","wikidata":"https://www.wikidata.org/wiki/Q5037837","display_name":"Carbapenem-resistant enterobacteriaceae","level":5,"score":0.5909262895584106},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5170465111732483},{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.4610203504562378},{"id":"https://openalex.org/C2909713668","wikidata":"https://www.wikidata.org/wiki/Q632006","display_name":"Gram-negative bacterial infections","level":3,"score":0.41875797510147095},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.3435298800468445},{"id":"https://openalex.org/C2778910516","wikidata":"https://www.wikidata.org/wiki/Q380136","display_name":"Enterobacteriaceae","level":4,"score":0.2612714469432831},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.2532047629356384},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.21200409531593323},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1738709807395935},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16257783770561218},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.13603001832962036},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.13182538747787476},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.10698634386062622},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000046","descriptor_name":"Academic Medical Centers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077731","descriptor_name":"Meropenem","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001618","descriptor_name":"beta-Lactamases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007711","descriptor_name":"Klebsiella pneumoniae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015780","descriptor_name":"Carbapenems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/23744235.2023.2177337","doi":"https://doi.org/10.1080/23744235.2023.2177337","is_oa":false,"landing_page_url":"https://doi.org/10.1080/23744235.2023.2177337","pdf_url":null,"source":{"id":"https://openalex.org/S200495913","display_name":"Scandinavian Journal of Infectious Diseases","issn_l":"0036-5548","issn":["0036-5548","1651-1980","2374-4235","2374-4243"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:36772806","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36772806","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious diseases (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2519197882","https://openalex.org/W2527983258","https://openalex.org/W2565726837","https://openalex.org/W2618911885","https://openalex.org/W2766370714","https://openalex.org/W2792380978","https://openalex.org/W2889629084","https://openalex.org/W2895593384","https://openalex.org/W2909686608","https://openalex.org/W3172169842","https://openalex.org/W3215068065","https://openalex.org/W4230258577"],"related_works":["https://openalex.org/W4406945409","https://openalex.org/W2895487706","https://openalex.org/W3007464332","https://openalex.org/W4405823244","https://openalex.org/W3118439655","https://openalex.org/W4416361152","https://openalex.org/W2981814659","https://openalex.org/W2790278722","https://openalex.org/W4389031350","https://openalex.org/W7204969109"],"abstract_inverted_index":{"Background":[0],"Carbapenem-resistant":[1],"Enterobacterales":[2],"(CRE)":[3],"are":[4],"considered":[5],"an":[6],"urgent":[7],"threat.":[8],"Ceftazidime-avibactam":[9],"and":[10,109,122,138,151,168,184,207,224,231,261],"meropenem-vaborbactam":[11,93,130],"contain":[12],"\u03b2-lactamase":[13],"inhibitors":[14],"active":[15],"against":[16],"CRE":[17,31,254],"isolates":[18,32,71,74,134],"including":[19],"those":[20],"that":[21],"produce":[22],"Klebsiella":[23],"pneumoniae":[24],"carbapenemases":[25],"(KPC).Methods":[26],"Retrospective":[27],"chart":[28],"review":[29],"of":[30,47,239],"from":[33,79,236],"1":[34,38],"January":[35],"2016":[36],"to":[37],"November":[39],"2018.":[40],"Collected":[41],"data":[42],"includes":[43],"a":[44,54,250,264],"descriptive":[45],"overview":[46],"measured":[48],"MIC":[49,259],"values,":[50],"resistance":[51],"mechanism":[52],"via":[53],"polymerase":[55],"chain":[56],"reaction":[57],"test":[58],"(Xpert":[59],"Carba-R,":[60],"Cepheid,":[61],"Sunnyvale":[62],"CA),":[63],"as":[64,66,249],"well":[65],"clinical":[67],"outcomes.Results":[68],"Of":[69],"106":[70],"reviewed,":[72],"86":[73],"met":[75],"the":[76,237],"inclusion":[77],"criteria":[78],"85":[80],"individual":[81],"subjects.":[82],"The":[83,129,182],"breakpoint:MIC":[84],"ratio":[85,95],"for":[86,92,132,253,268],"ceftazidime-avibactam":[87,104,166,198,240],"overall":[88],"was":[89,96,160,187,226],"4,":[90],"while":[91],"this":[94],"32":[97],"(p":[98,179,204,213],"<":[99],"0.0001).":[100],"For":[101,217],"KPC":[102,133],"isolates,":[103],"MIC50/MIC90":[105],"in":[106,135,165,173,190,221],"2016,":[107,136,222],"2017,":[108,137,223],"2018":[110,139,225],"were":[111,140],"2/4":[112,117],"mg/L":[113,118,124,142,147,153],"(n":[114,119,125,143,148,154,162,170],"=":[115,120,126,144,149,155,163,171,180,205,214],"32),":[116,145],"17),":[121,150],"2/8":[123],"30),":[127,156],"respectively.":[128,157,216],"MIC50/MIC90,":[131],"0.06/0.125":[141],"0.06/0.1":[146],"0.06/0.5":[152],"Microbiologic":[158],"cure":[159],"75%":[161],"16)":[164],"subjects":[167,174,191],"58.3%":[169],"12)":[172],"treated":[175,192],"with":[176,193],"alternative":[177],"agents":[178,195],"0.43).":[181],"14-":[183],"30-day":[185,219],"mortality":[186,220],"numerically":[188],"higher":[189],"alternate":[194],"when":[196],"compared":[197],"2/9":[199],"(22.2%)":[200],"vs":[201,210],"3/17":[202],"(17.6%)":[203],"1.00)":[206],"4/9":[208],"(44.4%)":[209],"4/17":[211],"(28.6%)":[212],"0.38),":[215],"ceftazidime-avibactam,":[218],"0/5":[227],"(0%),":[228,230],"0/2":[229],"4/10":[232],"(40%).Conclusion":[233],"Selective":[234],"pressure":[235],"use":[238],"at":[241],"our":[242],"institution":[243],"may":[244,262],"be":[245,263],"decreasing":[246],"its":[247],"utility":[248],"first-line":[251],"agent":[252],"infections.":[255],"Meropenem-vaborbactam":[256],"maintained":[257],"low":[258],"values":[260],"promising":[265],"treatment":[266],"option":[267],"CRE.":[269]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-02-12T00:00:00"}